Management of perioperative bleeding in renal patients;Manejo de la hemorragia perioperatoria en el paciente renal

Nefrologia

Volumn 28, Issue 6, 2008, Pages 593-596

  Heras Benito, M ^a   Sanchez Hernandez R ^a   Fernandez Reyes M J ^a   Isabel Diez Lobo A ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; HUMAN; KIDNEY DISEASE; POSTOPERATIVE HEMORRHAGE; REVIEW;

CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; POSTOPERATIVE HEMORRHAGE;

EID: 59049097541     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (34)

1. Krishnan M. Perioperative care of patients with kidney disease. American Family Phisician 2002; 66: 1471-1476.
2. Kidney Disease Outcome Quality Inititative: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S76-S92.
3. Rath CE, Mailliard JA, Schreiner GE. Bleeding tendency in uremia. N Engl J Med 1957; 257: 808-811.
4. Sohal AS, Gangji AS, Crowther MA, Treleaven D. Uremic bleeding: pathophysiology and clinical risk factors. Thrombosis Research 2006; 118: 417-422.
5. Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost 2005; 31: 381-392.
6. Seegmiller A, Sarode R. Laboratory evaluation of platelet function. Hematol Oncol Clin North Am 2007; 21: 731-742.
7. Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost 2004; 30: 579-589.
8. Rabolink TJ, Zwaginga JJ, Koomans HA, Sixta JJ. Thrombosis and hemostasis in renal failure. Kidney Int 1994; 46: 287-296.
9. Castillo R, Lozano T, Escolar G, Revert L, López J, Ordinas A. Defective platelet adhesion on vessel subendothelium in uremic patients. Blood 1986; 68: 337-342.
10. Remuzzi G, Cavenaghi AE, Mecca G, Donati MB, De Gaetano G. Prostacyclinlike activity and bleeding in renal failure. Lancet 1977; 2: 1195-1197.
11. Noris M, Benigni A, Boccardo P, Aiello S, Gaspari F, Todeschini M et al. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int 1993; 44: 445-450.
12. Eknoyan G, Brown CH. Biochemical abnormalities of platelets in renal failure. Evidence for decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Am J Nephrol 1981; 1: 17-23.
13. Remuzzi G, Benigni A, Dodesine P, Schieppati A, Livio M, De Gaetano G et al. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxigenase defect. J Clin Invest 1983; 71: 762-768.
14. Ware JA, Clark BA, Smith M, Salzman EW. Abnormalities of cytoplasmic Ca2+ in platelets from patients with uremia. Blood 1989; 73: 176-176.
15. Benigni A, Boccardo P, Galbusera M, Monteagudo J, De Marco, Remuzzi G e al. Reversible activation defect of the platelet glycoprotein IIb/IIIa complex in patients with uremia. Am J Kidney Dis 1993; 22: 668-676.
16. Eschbach JW. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989; 35: 134-148.
17. Sánchez Hernández R, Heras Benito M, Fernández-Reyes MJ, Álvarez-Ude F. Alteraciones de la hemostasia en el paciente con enfermedad renal. En: AI Díez Lobo. Mecidina Transfusional Perioperatoria. Ed Ergón, 2005: 217-232.
18. Livio M, Benigni A, Vigano G, Mecca G, Remuzzi G. Moderate doses of aspirin and risk of bleeding in renal failure. Lancet 1986; 1: 414-416.
19. Mosenkis A, Berns JS. Use of low molecular weight heparins and glycoprotein IIb/IIIa inhibitors in patients with chronic kidney disease. Semin Dial 2004; 17: 411-415.
20. Diuguid DL. Choosing a parenteral anticoagulant agent. N Engl J Med 2001; 345: 1340-1342.
21. Duplaga BA, Rivers CW, Nutescu E. Dosing and monitoring of low-molecular-weight heparins in special populations. Pharmacotherapy 2001; 21: 218-234.
22. Burroughs SF, Johnson GJ. Betalactam antibiotics inhibit agonist-stimulated plateled calcium influx. Thromb Haemost 1993; 69: 503-508.
23. Goldenberg NA, Jacobson L, Manco-Johnson MJ. Brief communication: duration of platelet dysfunction after a 7-day course of ibuprofen. Ann Intern Med 2005; 142: 506-509.
24. Onoyama K, Kumagai H, Miishima T, Tsuruda H, Tomooka S, Motomura K et al. Incidence of strokes and its prognosis in maintenance hemodialysis patients. Jpn Heart J 1986; 27: 685-691.
25. Quiroga T, Goycoolea M, Muñoz B et al. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhage: comparative study in 148 patients. J Thromb Haemost 2004; 2: 892-898.
26. Palesvski PM. Perioperative management of patients with chronic kidney disease or ESRD. Best Pract Res 2004; 18: 129-144.
27. Eschbach JW, Kelly MR, Halley NR et al. Treatment of the anemia of progressive renal failure with recombinant human erithropoietin. N Engl J Med 1989; 321: 158-163.
28. Poli F, Scalamogna M, Cardillo M, Porta E, Sirchia G. An algorithm for cadaver kidney allocation based on a multivariate analysis of factors impacting on cadaver kidney graft survival and function. Transpl Int 2000; 13 (S1): 259-262.
29. Hassan AA, Kroll MH. Acquired disorders of platelet function. Hematology/Am Society of Hematology. Education Program 2005: 403-408.
30. Mannucci PM, Remuzzi G, Pusineri F et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983; 303: 8-12.
31. Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ. Evidence-based treatment recommendations for uremic bleeding. Nature Clin Pract Nephrol 2007; 3: 138-153.
32. Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D. Treatment of bleeding tendency in uremia with cryoprecipitate. N Eng J Med 1980; 303: 1318-1322.
33. Livio M, Mannucci PM, Viganò G, Mingardi G, Lombardi R, Mecca G, Remuzzi G. Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 1986; 315: 731-735.
34. Downey P, Tagle R, Pereira J, Mezzano D. Tranexamic acid and uremic bleeding: evidence-based treatment recommendations. Nature Clin Pract Nephrol 2007; 3, E2.